TimesSquare Capital Management’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.8M Sell
951,637
-125,837
-12% -$4.87M 0.59% 64
2026
Q1
$40.6M Buy
1,077,474
+29,338
+3% +$958K 0.69% 54
2025
Q4
$31.5M Buy
1,048,136
+187,963
+22% +$5.32M 0.48% 81
2025
Q3
$22.6M Buy
860,173
+45,950
+6% +$1.1M 0.32% 106
2025
Q2
$17.4M Buy
+814,223
New +$18.4M 0.25% 120

Other funds holding GRDN

TimesSquare Capital Management's GRDN Position: Q2 2026 in Review

TimesSquare Capital Management reduced its Guardian Pharmacy Services (GRDN) stake by 12% in Q2 2026, selling an estimated $4.87M and leaving 951,637 shares worth $39.8M. The position accounts for 0.59% of the portfolio, ranked #64.

TimesSquare Capital Management first reported a position in GRDN in Q2 2025 and has held it in 5 quarters since. The position peaked at $40.6M in Q1 2026. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • TimesSquare Capital Management held 951,637 shares of Guardian Pharmacy Services worth $39.8M as of Q2 2026.
  • TimesSquare Capital Management sold 125,837 Guardian Pharmacy Services shares in Q2 2026, an estimated $4.87M.
  • Guardian Pharmacy Services made up 0.59% of TimesSquare Capital Management's portfolio in Q2 2026, its #64 holding.
  • TimesSquare Capital Management first reported a position in Guardian Pharmacy Services in Q2 2025 and has held it in 5 quarters since.
  • TimesSquare Capital Management's Guardian Pharmacy Services position peaked at $40.6M in Q1 2026.
  • 190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on TimesSquare Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.